First webinar of the series, From research and innovation to development: how to plan and execute translational projects in life sciences, From bench to bedside focuses on the process of creating new medicines. Matthias Versele, Executive Director Drug Discovery from Cistim, Belgium, presents CD3-Cistim’s strategy for the evaluation and execution of drug development projects.
Drawing on his experience in the UK and in continental Europe, Julian Jantke introduces a unique guided pathway approach, deployed in universities or at a national level, that uses valorisation as a tool to sustain and scale the impact of research in the SHAPE disciplines.
This webinar provides an accurate yet delightful introduction and discussion of the key IP Rights related to the protection of software innovation. In one hour Maurits Westerik provides insights on how Software IPR, and IPR in general, originated historically and get a new angle on how they can be used to provide a legal shelter to business based on software technologies, both in principle and with practical examples and anecdotes.
This report contains data of 674 KTOs from 21 European countries. It includes 97 aggregated KTO datasets from one National Association and 577 datasets from responding KTOs. The aggregated data was included in the summary overview and excluded from the detailed analysis in the remainder of the report to avoid biases.
This seminar investigates the importance of these non-financial impacts, such as social, cultural, and environmental contributions. Additionally, it suggests a very simple but still useful methodology that can be employed to assess and address these impacts. This seminar also highlights the integral role of KE professionals in bridging academia with industry and society, emphasising their efforts in promoting and measuring these impacts holistically.
Brechtje Vreenegoor is manager of the KTO Wageningen University and Research. She discussed ‘servitisation’ of open-source models. Numerous models are being valorised in different ways, but it is difficult to advise researchers on what they should do. Why does something work one time and not another? And do we even know what works: how do we determine success?
In this Tea with ASTP Clare Dillon, InnerSource Researcher at the University of Galway, covered where academic OSPOs are located within institutions, their goals and the activities OSPO staff engage in.
In this Tea with ASTP, Cornelia Peuser presents the EPO Observatory’s new Deep Tech Finder, a tool that blends the business profiles of around 8,300 investment-ready European start-ups with information on their patent portfolios.
The 7th ASTP- EU Forum continues the dialogue between European knowledge/technology transfer professionals and staff of the European Commission. At this free online event, you shall have the opportunity to hear directly from senior Commission staff working on initiatives which directly impact the innovation landscape.
A few years ago, the Max Planck Society introduced a partially standardised licensing model for spin-offs. The model includes a 10% stake of Max Planck in the companies and, in some cases, milestone payments or royalties. The model has proved to be successful in most cases. Only in the start-up projects, which are solely based on software code the model was sometimes considered unfair by the founders. The Max Planck Society has since then revised the model for these special technologies again.
In this Tea with ASTP, Relika Williams and Christophe Haunold were joined by other guests to share their experiences around creating, approving and executing IP management policy for universities. Three different perspectives: from a drafting point of view, an approval / feedback collection, and execution of a long standing policy. Why do we need it? What are the ingredients of a good policy? How to implement, approve and promote it?
The SynSICRIS tool supports project planning via an impact pathway and a working plan bar chart. This is combined with continous, project-related monitoring of potential impact. This open source tool is intended to create benefits for innovation, transfer and sustainability in the research and funding landscape. Birge shared her developer and user experiences.
Join our newsletter and get the latest news